Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic Acid in Lower Limb Trauma Surgery
NCT04986813Phase 4Completed
- Start
- Apr 2017
- Primary completion
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of tranexamic acid in lower extremity fracture (2 arms). Primary endpoint: Requirement of number of units of blood transfusion at 15 days. Started Apr 2017; status: completed.
02
Drugs
tranexamic acid
03
Conditions
lower extremity fracture
Beyond the preview
Go deeper on NCT04986813.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04986813.